Cargando…
SARS-CoV-2 Spike Glycoprotein S1 Induces Neuroinflammation in BV-2 Microglia
In addition to respiratory complications produced by SARS‐CoV‐2, accumulating evidence suggests that some neurological symptoms are associated with the disease caused by this coronavirus. In this study, we investigated the effects of the SARS‐CoV‐2 spike protein S1 stimulation on neuroinflammation i...
Autores principales: | Olajide, Olumayokun A., Iwuanyanwu, Victoria U., Adegbola, Oyinkansola D., Al-Hindawi, Alaa A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551352/ https://www.ncbi.nlm.nih.gov/pubmed/34709564 http://dx.doi.org/10.1007/s12035-021-02593-6 |
Ejemplares similares
-
Induction of Exaggerated Cytokine Production in Human Peripheral Blood Mononuclear Cells by a Recombinant SARS-CoV-2 Spike Glycoprotein S1 and Its Inhibition by Dexamethasone
por: Olajide, Olumayokun A., et al.
Publicado: (2021) -
Neuroprotection by Skimmianine in Lipopolysaccharide-Activated BV-2 Microglia
por: Ogunrinade, Folashade A., et al.
Publicado: (2023) -
Nimbolide Targets Multiple Signalling Pathways to Reduce Neuroinflammation in BV-2 Microglia
por: Katola, Folashade O., et al.
Publicado: (2023) -
AMPK and SIRT1 activation contribute to inhibition of neuroinflammation by thymoquinone in BV2 microglia
por: Velagapudi, Ravikanth, et al.
Publicado: (2017) -
Inhibition of Neuroinflammation in LPS-Activated Microglia by Cryptolepine
por: Olajide, Olumayokun A., et al.
Publicado: (2013)